IndraLab
Statements
reach
"In addition to USP22, many other downstream factors, such as breast cancer resistance protein of AKT, are involved in drug resistance of breast cancers (56); therefore, future works are needed to dissect each substrate of phosphatidylinositol 3-kinase–AKT pathways in breast cancer tumorigenesis.One unexpected observation is the EPI-induced posttranscriptional stabilization of USP22, the cancer stem cell gene with increased expression in breast cancer stem cells (18)."